๐ฌDeep Research
SRPT โ Sarepta Therapeutics ยท catalysts, narrative & risks
Sarepta Therapeutics (SRPT) โ Point-in-Time Research Summary (as of 2026-10-28)
Valuation Snapshot
As of the latest prints on October 27โ28, 2026, SRPT traded near ~$19โ20, with a market capitalization of roughly $1.9Bโ$2.0B, and a 52-week range of approximately $14.68โ$24.68 [17], [26], [27]. The stock is down roughly 12.2% year-to-date and about 19.6% over the past year, sitting roughly mid-range on its 52-week band [17], [26], [27]. It is not part of a major index such as the S&P 500 [8].
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ